This means a chromosome is more likely to break or change shape. It's like a chromosome that's a bit fragile and can break easily under certain conditions.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Chromosome fragility means that a person's chromosomes, the packages that hold DNA inside each cell, break more easily than usual. Breaks that are not repaired correctly can leave pieces of a chromosome missing, reversed or attached to the wrong chromosome. Over time, that damage can disrupt how cells grow and can make cancer more likely. In medicine, chromosome fragility is usually discussed as a shared feature of a small group of rare inherited conditions called chromosome instability or chromosome breakage syndromes. The best known are Fanconi anemia, ataxia-telangiectasia, Nijmegen breakage syndrome and Bloom syndrome. They are distinct conditions with different effects. Fanconi anemia often causes bone marrow failure (the marrow stops making enough blood cells), short stature and differences in the thumbs or forearms. Ataxia-telangiectasia is a progressive nervous system condition that starts in early childhood and affects balance and coordination. Nijmegen breakage syndrome causes a small head size, slow growth and a weak immune system. Bloom syndrome causes very small body size, a sun-sensitive facial rash and frequent infections. What they share is a raised risk of cancer, often at a young age, and unusual sensitivity of their cells to some kinds of DNA damage. The term also has a narrower laboratory meaning. Some chromosomes have fragile sites, spots that show up as gaps when cells are grown under special conditions. Fragile X syndrome is named after one of these sites, but it is a separate condition with a different cause.
The chromosome breakage syndromes are genetic. Each is caused by changes in a gene that helps the cell find and repair damaged DNA. Ataxia-telangiectasia, Nijmegen breakage syndrome and Bloom syndrome are each linked to a single gene, while Fanconi anemia can result from changes in any of more than 20 genes. When that repair system does not work, everyday DNA damage builds up as broken and rearranged chromosomes. Most of these conditions are inherited in a recessive pattern: a child is affected when both parents pass on an altered copy of the same gene. Parents who carry one altered copy are usually healthy, and when both parents are carriers, each pregnancy has a one in four chance of an affected child. Some variants are more common in particular communities because of shared ancestry, for example Fanconi anemia and Bloom syndrome in people of Ashkenazi Jewish descent and Nijmegen breakage syndrome in people of Slavic descent. Carriers of some of these genes may themselves have a somewhat higher cancer risk, which is one reason relatives are often offered testing. Nothing a parent did during pregnancy causes these conditions. Exposures such as radiation can break chromosomes in anyone, but they do not create an inherited breakage syndrome.
A diagnosis usually starts with a pattern a clinician recognizes: a child with poor growth and unusual birth differences, unexplained low blood counts, early cancer, repeated infections, or balance problems in a young child. Because each syndrome looks different, a clinical geneticist or other specialist is often involved, and the path to a diagnosis can take years. Laboratory tests then look for the fragility itself. For Fanconi anemia, a chromosome breakage test exposes a blood sample to chemicals called diepoxybutane (DEB) or mitomycin C (MMC), which damage DNA in a specific way. Cells from someone with Fanconi anemia show far more broken chromosomes than normal cells. Bloom syndrome can be detected with a test that counts exchanges between paired chromosome strands. In ataxia-telangiectasia, a blood protein called alpha-fetoprotein (AFP) is raised in nearly all affected people after age one, and specialized tests can show that the repair protein affected in this condition is missing or inactive. Genetic testing identifies the exact gene change and is how most diagnoses are confirmed. Knowing the variants makes it possible to test brothers and sisters, offer carrier testing to relatives and offer testing in future pregnancies. Some infants with ataxia-telangiectasia or Nijmegen breakage syndrome are now found through newborn screening for severe immune deficiency. A standard karyotype, a picture of a person's chromosomes, can show rearrangements but is not enough on its own to diagnose these syndromes.
There is no treatment that repairs the underlying DNA repair defect. Care focuses on preventing and treating the complications each syndrome causes, ideally coordinated by a center with experience in that condition. Cancer surveillance is a shared part of care. Each syndrome has its own pattern of cancer risk, so checks are tailored: for example, regular blood counts and bone marrow checks plus head, neck and mouth examinations in Fanconi anemia, and a schedule of imaging, colonoscopy and skin checks in Bloom syndrome. The aim is to find cancers early, when surgery or treatment is more likely to work. For Fanconi anemia, the main treatment for failing bone marrow is a stem cell (bone marrow) transplant. When it goes well, it restores blood cell production and removes the risk of leukemia arising from the marrow, but it does not correct the other effects of the condition and can increase and speed up later cancers, especially of the head and neck. Hormone treatments called androgens can raise blood counts for a time in some people. Gene therapy is still experimental. For ataxia-telangiectasia, no treatment slows the nervous system decline, but physical, occupational and speech therapy, medicines for movement symptoms, nutrition support and close attention to the lungs help with daily function. Across these syndromes, people with weak antibody responses may receive immunoglobulin (antibody) replacement to reduce infections. One trade-off matters for everyone with these conditions. Their cells are unusually sensitive to radiation and to some chemotherapy drugs, so standard cancer treatment doses can cause severe harm. Cancer treatment usually needs reduced doses, avoids certain drugs and limits radiation, and should be planned with specialists who know the syndrome.
The outlook depends heavily on which syndrome a person has and how severe it is. Some people with a mild form of Fanconi anemia live a nearly normal life into their thirties or forties before the diagnosis is even made, while others need a transplant in childhood. Ataxia-telangiectasia usually progresses, and most people need a wheelchair by adolescence. Most people with Bloom syndrome have normal intelligence and fairly ordinary daily lives, apart from sun protection and their small size, but face a high risk of cancer in early adulthood. In every case, the condition is lifelong and involves regular appointments with several specialists, such as hematology, immunology, neurology, cancer care and genetics. Surveillance is ongoing rather than a one-time check, and the focus can shift with age: blood and growth problems in childhood, then cancer screening, hormones, fertility and organ health in adulthood. Survival has improved in recent decades as transplants and specialist care have improved. The diagnosis also affects the wider family. Parents often face a long search for answers before a diagnosis, then decisions about testing other children and future pregnancies. Patient organizations exist for each of these syndromes and can connect families with experienced centers and with each other.
Ask about an evaluation for a breakage syndrome when a child has a combination of poor growth, birth differences of the thumbs or forearms, unexplained low blood counts, repeated serious infections or worsening balance in early childhood, or when cancer appears unusually young or a relative has a known diagnosis. Genetic counseling is worth arranging before a pregnancy when either partner carries a known variant. For someone already diagnosed, contact the care team promptly about new easy bruising or bleeding, frequent or unusual infections, growing tiredness, or any unexplained new symptom such as a lump, weight loss or a mouth sore that does not heal, since cancer can appear at any age. Before any X-rays, scans that use radiation, radiation therapy or chemotherapy, make sure every clinician involved knows the diagnosis.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Chromosome Fragility is like, what's helped you, or ask the community a question.